Journal of Surgical Oncology

Publication Venue For
- Impact of time-to-surgery on outcomes of patients undergoing curative-intent liver resection for BCLC-0, A and B hepatocellular carcinoma.. 123:381-388. 2021
- A clinical-radiomic model for improved prognostication of surgical candidates with colorectal liver metastases. 2019
- Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi-institutional analysis of 706 patients.. 120:206-213. 2019
- The optimal number of lymph nodes to evaluate among patients undergoing surgery for gallbladder cancer: Correlating the number of nodes removed with survival in 6531 patients.. 119:1099-1107. 2019
- Laparoscopic synchronous resection of colorectal cancer and liver metastases: A systematic review.. 119:30-39. 2019
- Safety and oncologic outcomes of robotic liver resections: A systematic review.. 117:1517-1530. 2018
- Management, outcomes, and prognostic factors of ruptured hepatocellular carcinoma: A systematic review.. 117:341-353. 2018
- Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis.. 116:643-650. 2017
- Liver transplantation for unresectable colorectal liver metastases: A systematic review.. 116:288-297. 2017
- Non-ampullary duodenal adenocarcinoma: Factors important for relapse and survival (Journal of Surgical Oncology (2009) 100, 2, (144-148)). 100:434. 2009
- Can surgeons improve survival in stage IV melanoma?. 97:462-468. 2008
- The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma—with special reference to the serum levels of des-gamma-carboxy prothrombin. 95:235-240. 2007
- Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935.. 94:599-606. 2006
- The Kraske procedure: a critical analysis of a surgical approach for mid-rectal lesions.. 94:194-202. 2006
- Submucosal resection of giant gastric lipoma.. 94:63-67. 2006
- Expression of chymase-positive cells in gastric cancer and its correlation with the angiogenesis: Commentary. 93:42-43. 2006
- Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab.. 91:173-180. 2005
- Mucosal melanoma.. 86:187-188. 2004
- Mitochondrial DNA alterations in thyroid cancer.. 82:170-173. 2003
- Heterotopic ossification in rectal cancer: Rare finding with a novel proposed mechanism.. 82:132-136. 2003
- Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection.. 78:162-170. 2001
- FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume.. 77:237-242. 2001
- Recurrent ductal carcinoma in situ after total mastectomy.. 71:182-185. 1999
- MCA106 fibrosarcoma cells transduced with granulocyte/macrophage colony-stimulating factor are not superior to the wild-type cells in suppressing the growth of hepatic metastases.. 71:36-45. 1999
- Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice.. 68:79-91. 1998
- Prognostic value of MIB-1 in advanced ovarian carcinoma as determined using automated immunohistochemistry and quantitative image analysis.. 66:230-236. 1997
- Primary malignant melanoma of the esophagus.. 66:201-206. 1997
- Appendiceal carcinoma: patterns of failure following surgery and implications for adjuvant therapy.. 66:51-53. 1997
- Interlaboratory variation in oxygen tension measurement by Eppendorf "Histograph" and comparison with hypoxic marker.. 66:30-38. 1997
- Prognostic factors for fibromatoses: a correlation of proliferation index, estrogen receptor, p53, retinoblastoma, and src gene products and clinical features with outcome.. 65:117-122. 1997
- Intratumoral heterogeneity in primary breast carcinoma: study of concurrent parameters.. 64:280-287. 1997
- Long-term results of therapy for stage C neuroblastoma.. 63:172-178. 1996
- Correlation of DNA ploidy and histologic diagnosis from prostate core-needle biopsies: is DNA ploidy more sensitive than histology for the diagnosis of carcinoma in small specimens?. 63:41-45. 1996
- Prognostic value of BHCG and local tumor invasion in stage I seminoma of the testis.. 61:131-133. 1996
- Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer.. 60:122-127. 1995
- Clinical outcome after neoadjuvant thermoradiotherapy in high grade soft tissue sarcomas.. 57:143-151. 1994
- Intraportal injection of monoclonal antibody in nude mice bearing hepatic metastases.. 54:71-77. 1993
- Flow cytometric DNA analysis of interleukin-2 responsive renal cell carcinoma.. 53:252-255. 1993
- A phase I/II study of intraoperative radiotherapy in advanced unresectable or recurrent carcinoma of the rectum: a Radiation Therapy Oncology Group (RTOG) study.. 53:20-29. 1993
- Substituting ornithine for arginine in total parenteral nutrition eliminates enhanced tumor growth.. 50:161-167. 1992
- Endobronchial interstitial Au-198 implantation in the treatment of recurrent bronchogenic carcinoma.. 49:213-219. 1992
- p53 alterations in all stages of breast cancer.. 48:260-267. 1991
- Proliferation index in various stages of breast cancer determined by Ki-67 immunostaining.. 48:11-20. 1991
- Colorectal ornithine decarboxylase activity in human mucosa and tumors: elevation of enzymatic activity in distal mucosa.. 47:117-120. 1991
- Acral melanoma: a review of 185 patients with identification of prognostic variables.. 45:91-98. 1990
- Effects of hyperthermia and irradiation on the growth of mouse melanoma tumors following immunotherapy.. 44:256-259. 1990
- Inhibition of the growth of human melanoma xenografts in nude mice by human tumor-specific cytotoxic T-cells.. 43:67-72. 1990
- Surgery in patients with unsuspected pheochromocytomas.. 41:65-69. 1989
- Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients.. 39:139-147. 1988
- Biochemical and ultrastructural differences between muco-epidermoid and carcinoid tumors of the bronchus.. 37:227-231. 1988
- Plasma proteins as indices of response to nutritional therapy in cancer patients.. 29:160-165. 1985
- Immunodiagnosis of tumors in vivo using radiolabeled monoclonal antibody A2B5.. 23:205-211. 1983
- Human melanoma growth in the peritoneal cavity of the athymic mouse--a model for in vivo study of cell-mediated immunity.. 17:309-320. 1981
- In vivo evaluation of cell mediated immunity against human melanoma.. 17:263-278. 1981
- Influence of mouse hepatitis virus on the growth of human melanoma in the peritoneal cavity of the athymic mouse.. 17:327-339. 1981
- Characterization of melanoma cell membrane tumor-associated antigens using xenoserum, alloserum, and autoserum: I. immunofluorescence.. 14:367-377. 1980
- Non-specific and specific active immunotherapy in a B16 murine melanoma system.. 12:87-96. 1979
- Production and secretion of proteolytic enzymes by normal and neoplastic cells.. 11:275-282. 1979
- Establishment of a nude mouse model of hepatic metastasis for evaluation of targeted retroviral gene delivery: Commentary. 82:131. 2003
- Patterns of recurrence of colorectal cancer. 2008

Publication Venue For